The forecasted sales of obstructive airway diseases medicine in Italy show a declining trend from 2024 onwards. In 2023, the actual sales value stood at approximately 1.09 billion USD. From 2024 to 2028, sales are anticipated to decrease from 1.07 billion USD to 0.9884 billion USD, reflecting a continuous year-over-year reduction. The compound annual growth rate (CAGR) from 2024 to 2028 is negative, indicating a contraction in the market over these years.

Future trends to watch for include:

Advancements in medicine that may alter treatment protocols, impacting sales.
Government healthcare policies and their potential effects on pharmaceutical pricing.
The emergence of new competitors or generic medicines potentially affecting market dynamics.
Trends in disease prevalence which might influence treatment demand.